{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:14:49Z","timestamp":1761174889917,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cmi.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:02:26Z","timestamp":1680951746000},"page":"959-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Which trial do we need? Bundle including antibiotic monitoring, rapid antibiotic susceptibility testing and molecular biology in septic shock"],"prefix":"10.1016","volume":"29","author":[{"given":"Emmanuel","family":"Dudoignon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefine","family":"Baekgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"D\u00e9pret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.04.003_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(17)31833-0","article-title":"Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","article-title":"Rationalizing antimicrobial therapy in the ICU: a narrative review","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1378\/chest.123.5.1615","article-title":"Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival","volume":"123","author":"Vall\u00e9s","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2023.04.003_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00134-022-06969-7","article-title":"Advancing precision-based antimicrobial dosing in critically ill patients","volume":"49","author":"Cotta","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40262-017-0572-y","article-title":"Intracellular pharmacokinetics of antibacterials and their clinical implications intracellular pharmacokinetics of antibacterials and their clinical implications","volume":"57","author":"Pea","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2147\/IDR.S213183","article-title":"Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic\/pharmacodynamic target in Asian ICU population: a prospective observational study","volume":"12","author":"Wu","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2023.04.003_bib13","first-page":"3178","article-title":"Therapeutic drug monitoring of the \u03b2-lactam antibiotics: what is the evidence and which patients should we be using it for?","volume":"70","author":"Huttner","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijantimicag.2013.06.021","article-title":"Can changes in renal function predict variations in \u03b2-lactam concentrations in septic patients?","volume":"42","author":"Casu","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1164\/rccm.201601-0024OC","article-title":"Continuous versus intermittent \u03b2-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials","volume":"194","author":"Roberts","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2023.04.003_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2023.04.003_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.idnow.2022.09.002","article-title":"Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection","volume":"52","author":"Cardot Martin","year":"2022","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.cmi.2023.04.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2022.106433","article-title":"Antimicrobial susceptibility testing determined by Alfred 60\/AST (Alifax\u00ae) in a multi-sites lab: performance\u2019s evaluation and optimization of workflow","volume":"194","author":"Cupaiolo","year":"2022","journal-title":"J\u00a0Microbiol Methods"},{"key":"10.1016\/j.cmi.2023.04.003_bib20","doi-asserted-by":"crossref","first-page":"j3064","DOI":"10.1136\/bmj.j3064","article-title":"How to design efficient cluster randomised trials","volume":"358","author":"Hemming","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0310057X0703500409","article-title":"Combining sequential organ failure assessment (SOFA) score with acute physiology and chronic health evaluation (APACHE) II score to predict hospital mortality of critically ill patients","volume":"35","author":"Ho","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.cmi.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13054-016-1522-z","article-title":"Not all \u03b2-lactams are equal regarding neurotoxicity","volume":"20","author":"Cha\u00efbi","year":"2016","journal-title":"Crit Care"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23001568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23001568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:36:03Z","timestamp":1761118563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23001568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1198743X23001568"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.04.003","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which trial do we need? Bundle including antibiotic monitoring, rapid antibiotic susceptibility testing and molecular biology in septic shock","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}